Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002604585 | SCV002967903 | pathogenic | not provided | 2024-12-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu434Lysfs*2) in the CFI gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CFI are known to be pathogenic (PMID: 15917334, 16621965, 19065647, 20016463, 22710145). This variant is present in population databases (rs757053954, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with CFI-related conditions. ClinVar contains an entry for this variant (Variation ID: 1923366). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005025900 | SCV005658380 | likely pathogenic | Atypical hemolytic-uremic syndrome with I factor anomaly; Age related macular degeneration 13; Factor I deficiency | 2024-04-06 | criteria provided, single submitter | clinical testing |